"10.1371_journal.pone.0144834","plos one","2016-01-15T00:00:00Z","Heinz Wiendl; Helmut Butzkueven; Ludwig Kappos; Maria Trojano; Fabio Pellegrini; Dominic Paes; Annie Zhang; Shibeshih Belachew; Tysabri ® Observational Program (TOP) Investigators","Department of Neurology–Inflammatory Disorders of the Nervous System and Neurooncology, University of Münster, Münster, Germany; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia; Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia; Department of Neurology, Box Hill Hospital, Monash University, Victoria, Australia; Neurology, Department of Medicine, University Hospital Basel, Basel, Switzerland; Neurology, Department of Clinical Research, University Hospital Basel, Basel, Switzerland; Neurology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland; Department of Neuroscience and Sense Organs, University of Bari, Bari, Italy; Biogen, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: HW HB LK MT FP DP AZ SB. Performed the experiments: HW HB LK MT FP DP AZ SB. Analyzed the data: FP AZ. Wrote the paper: HW HB LK MT FP DP AZ SB.","HW has received honoraria from Bayer, Biogen, Medac, Merck Serono, Novo Nordisk, Sanofi, Schering, and Teva; has been a consultant for Bayer Vital/Schering, Biogen, Medac, Merck Serono, Novartis, Novo Nordisk, Sanofi, and Teva; and has received research support from Bayer, Biogen, Medac, Merck Serono, Novo Nordisk, Sanofi, Schering, and Teva. HB has received compensation for consulting from Biogen, Merck Serono, Novartis; and has received research support from Biogen and Merck Serono. LKs institution (University Hospital Basel) has received research support from Actelion, Addex, Bayer Health Care, Biogen, Biotica, CSL Behring, Genzyme, Lilly, Merck, Mitsubishi, Neurostatus Systems, Novartis, Ono Pharma, Pfizer, Receptos, Roche, Sanofi, Santhera, Siemens, Teva, UCB, Xenoport, the European Union, the Roche Research Foundation, the Swiss MS Society, and the Swiss National Research Foundation. MT has participated in scientific advisory boards for Biogen, Merck Serono, and Novartis; has received speaker honoraria from Biogen, Merck Serono, Novartis, Sanofi, and Teva; and has received research grants from Biogen, Merck Serono, and Novartis. FP, DP, AZ, and SB are employees of the study sponsor, Biogen.","2016","01","Heinz Wiendl","HW",9,TRUE,8,8,2,8,TRUE,FALSE,TRUE,1,"9",TRUE
